Hear why Science Corp CEO Max Hodak says the screen era is ending at TechCrunch Disrupt 2026

Science Corporation CEO Max Hodak forecasts a shift away from traditional computer interfaces at TechCrunch Disrupt 2026. Hodak's company is leading the first U.S. human trials of a biohybrid brain-computer interface, developed with the help of a top neurobiologist. Hodak presented his company's progress at the Beyond Screens session during the tech conference in San Francisco.

He argues that future technology should focus on brain-computer interactions and new ways of engaging with machines. Hodak's career is marked by a belief in improving the interface between humans and machines. He has a background in programming, biomedical engineering, and neuroengineering, having co-founded companies such as Transcriptic and Neuralink.

Science Corporation, founded in 2021, has developed advanced neural engineering and brain-computer interface technology, with a focus on vision, cognition, and mobility applications. The company's PRIMA implant has restored eyesight for individuals with severe vision loss. Hodak envisions brain-implanted sensors aiding in treating brain damage, seizures, and potentially even conditions like Parkinson's disease.

This is a unique opportunity to learn about Hodak's vision for the future of human-machine interaction and how it could impact various aspects of startups, roles, and lives.